000 01276 a2200385 4500
005 20250512022657.0
264 0 _c19850306
008 198503s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(85)91903-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSomerville, K W
245 0 0 _aSomatostatin in treatment of haematemesis and melaena.
_h[electronic resource]
260 _bLancet (London, England)
_cJan 1985
300 _a130-2 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aClinical Trials as Topic
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHematemesis
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMelena
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aRandom Allocation
650 0 4 _aRecurrence
650 0 4 _aSomatostatin
_xtherapeutic use
700 1 _aHenry, D A
700 1 _aDavies, J G
700 1 _aHine, K R
700 1 _aHawkey, C J
700 1 _aLangman, M J
773 0 _tLancet (London, England)
_gvol. 1
_gno. 8421
_gp. 130-2
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(85)91903-8
_zAvailable from publisher's website
999 _c2863058
_d2863058